跳至主要内容
临床试验/NCT01775267
NCT01775267终止2 期

ASSOCIATING LIVER PARTITION WITH PORTAL VEIN LIGATION FOR STAGED HEPATECTOMY (ALPPS) Versus Conventional Portal Vein Occlusion (PVO) for Resection of Liver Tumors Unresectable in One Step - a Randomized Controlled Trial

University of Zurich4 个研究点 分布在 3 个国家目标入组 7 人开始时间: 2012年11月最近更新:
适应症

试验速览

阶段
2 期
状态
终止
入组人数
7
试验地点
4
主要终点
Liver free of tumors [ Time Frame: At 3 months ] [ Designated as safety issue: No ]

研究概览

简要总结

This randomized phase II trial compares how well associating liver partition with portal vein ligation for staged hepatectomy (ALPPS) or portal vein occlusion (PVO) works in treating patients with liver cancer. Both treatments are types of 2-stage hepatectomies for removing liver cancer. ALPPS may be more effective than PVO in patients whose disease would traditionally be considered inoperable.

  • Trial with surgical intervention

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Liver free of tumors [ Time Frame: At 3 months ] [ Designated as safety issue: No ]

时间窗: 2012 to 2015

次要结局

  • rate of hypertrophy over time(2012 to 2015)
  • Complications of treatment(2012-2015)
  • Postoperative liver and renal function(2012 to 2015)
  • Progression of disease(2012-2015)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验